Anterix (ATEX) Cost of Revenue (2016 - 2025)
Anterix filings provide 13 years of Cost of Revenue readings, the most recent being $1.4 million for Q4 2025.
- On a quarterly basis, Cost of Revenue rose 9.93% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.0 million, a 4.31% decrease, with the full-year FY2025 number at $6.1 million, up 7.32% from a year prior.
- Cost of Revenue hit $1.4 million in Q4 2025 for Anterix, down from $1.4 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $1.9 million in Q1 2023 to a low of -$464000.0 in Q1 2021.
- Median Cost of Revenue over the past 5 years was $1.4 million (2024), compared with a mean of $1.3 million.
- The widest YoY moves for Cost of Revenue: up 92.82% in 2021, down 179.32% in 2021.
- Anterix's Cost of Revenue stood at $1.3 million in 2021, then rose by 9.66% to $1.4 million in 2022, then dropped by 0.36% to $1.4 million in 2023, then decreased by 5.14% to $1.3 million in 2024, then increased by 9.93% to $1.4 million in 2025.
- The last three reported values for Cost of Revenue were $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.